Speakers

Mr Dimitrios Mantzilas, CTO, Precirix

photo of Mr Dimitrios Mantzilas

Passionate about advancing healthcare through radiopharmaceuticals

As a dedicated professional and pioneer in the field of radiopharmaceuticals, I bring a wealth of experience and expertise in the dynamic intersection of nuclear medicine and pharmaceuticals. My mission is to contribute to the advancement of healthcare by leveraging the power of radiopharmaceuticals to diagnose and treat diseases.

Over the years, I have been at the forefront of cutting-edge research, development, and production of radiopharmaceuticals that play a pivotal role in personalized medicine. I thrive on the challenges of innovating within a rapidly evolving industry, always seeking novel solutions to enhance diagnostic accuracy and therapeutic efficacy.

Having successfully navigated the complexities of regulatory frameworks, I have a proven track record of bringing radiopharmaceuticals from concept to market. My commitment to excellence extends beyond the laboratory, as I actively engage in industry conferences, share insights, and collaborate with professionals to stay ahead of the curve.

Let's connect to explore opportunities for collaboration, knowledge exchange, and mutually beneficial partnerships. Together, let's drive innovation in radiopharmaceuticals to make a lasting impact on patient outcomes and contribute to the future of healthcare.

Presentation Title: Sourcing Radiopharmaceutical Manufacturing Expertise

Abstract: Radiopharmaceuticals play a pivotal role in modern medicine, offering targeted diagnostic and therapeutic solutions for a myriad of diseases, including cancer. However, the production of these specialized drugs demands a unique set of expertise and resources. This talk delves into the challenges and strategies involved in sourcing radiopharmaceutical manufacturing expertise.
We will explore the intricate landscape of radiopharmaceutical production, considering the regulatory frameworks, technological advancements, and logistical complexities that define the field.

View company profile